<p>Efficacy and Resistance of ALK Inhibitors in Two Inflammatory Myofibroblastic Tumor Patients with ALK Fusions Assessed by Whole Exome and RNA Sequencing</p>-Reference-Cited by-同舟云学术

Efficacy and Resistance of ALK Inhibitors in Two Inflammatory Myofibroblastic Tumor Patients with ALK Fusions Assessed by Whole Exome and RNA Sequencing

Published:2020-10 Issue: Volume:Volume 13 Page:10335-10342
ISSN:1178-6930
Container-title:OncoTargets and Therapy
language:en
Short-container-title:OTT

Author:

Zhang Chenlu,Wang Zhiming,Zhuang Rongyuan^ORCID,Guo Xi,Feng Yi,Shen Feng^ORCID,Liu Wenshuai,Zhang Yong,Tong Hanxing,Sun Wending,Liu Jun,Wang Guan,Dai Chun,Lu Weiqi,Zhou Yuhong

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Reference30 articles.

1. Inflammatory Myofibroblastic Tumors Harbor Multiple Potentially Actionable Kinase Fusions

2. Inflammatory Myofibroblastic Tumors of the Female Genital Tract Are Under-recognized

3. ALK1 and p80 Expression and Chromosomal Rearrangements Involving 2p23 in Inflammatory Myofibroblastic Tumor

4. Tyrosine kinase gene rearrangements in epithelial malignancies

5. Identification of CARS-ALK Fusion in Primary and Metastatic Lesions of an Inflammatory Myofibroblastic Tumor

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IC Regimen: Delaying Resistance to Lorlatinib in ALK Driven Cancers by Adding Repurposed Itraconazole and Cilostazol;Cells;2024-07-10

2. Inflammatory myofibroblastic tumor from molecular diagnostics to current treatment;Oncology Research;2024

3. An Anaplastic Lymphoma Kinase-positive Inflammatory Myofibroblastic Tumor with Rapidly Acquired Resistance to First-line Anaplastic Lymphoma Kinase Inhibitor: A Case and Literature Review;Journal of Cancer Research and Practice;2024-01

4. Update of Diagnosis and Targeted Therapy for ALK+ Inflammation Myofibroblastic Tumor;Current Treatment Options in Oncology;2023-11-08

5. Inflammatory myofibroblastic tumors: recent progress and future of targeted therapy;Japanese Journal of Clinical Oncology;2023-07-01